WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 26th, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 26th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”) is entered into as of July 21, 2017, by and among OncoCyte Corporation, a California corporation (the “Company”), and [●] (the “Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 26th, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 26th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”) is entered into as of July 21, 2017, by and among OncoCyte Corporation, a California corporation (the “Company”), and [●] (the “Holder”).
WARRANT EXERCISE AGREEMENTWarrant Exercise Agreement • July 26th, 2017 • OncoCyte Corp • In vitro & in vivo diagnostic substances
Contract Type FiledJuly 26th, 2017 Company IndustryThis Warrant Exercise Agreement (this “Agreement”) is entered into as of July 21, 2017, by and among OncoCyte Corporation, a California corporation (the “Company”), and [●] (the “Holder”).